🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Congratulations to Joseph Antin, MD, recipient of the ASTCT Lifetime Achievement Award. This recognition is given to a physician who has made continuing contributions to the BMT and cellular therapy fields through the advancement of knowledge through basic or clinical science.

We are excited to honor the incredible physician-scientist ⁦⁦Kimryn Rathmell⁩ with ⁦American Cancer Society⁩ most important award. Her passion to combine science and care to improve patient outcomes with #kidneycancer is an inspiration to us all pressroom.cancer.org/2025MedalofHon…

Aplastic Anemia panel from the 2025 AAMDSIF Bone Marrow Failure Summit, featuring Monderator Emma Groarke, with Bhavisha Patel, Pedro Prata, Zoe McQuilten, and Tapan Kadia. #AplasticAnemia #bonemarrowfailure

Our pilot study using #WGS found no high prevalence of clonal hematopoiesis of indeterminate potential (#CHIP) in patients with severe chronic #GvHD Steven Pavletic M.D., Ph.D. Alain Mina Noa Holtzman, MD #alloHCT doi.org/10.1038/s41409…

New! Dr. Kenneth Pienta, an ACS Research Award recipient, discusses how evolutionary ecology principles can reshape our understanding of lethal cancer w/ colleagues Dr. Patrick Goodin & Sarah R. Amend, Ph.D.. Full article in CA: acsjournals.onlinelibrary.wiley.com/doi/full/10.33… Kenneth Pienta OncoAlert

This will be a terrific meeting!

ICYMI: Infectious disease expert Mark Rupp, MD, joins Jeffrey P. Gold, M.D. Jeffrey P. Gold, MD, on Rural Health Matters to discuss the resurgence of measles and its impact on public health. 📺 Tune in here: youtube.com/watch?v=rLS6ym…

In the latest episode of ASTCT Talks, Corey Cutler is joined by Steven Pavletic M.D., Ph.D., the GVHD and Late Effects Section and Myeloid Malignancies Program Director at NIH. Listen at the link here or wherever you get podcasts: ow.ly/x8oJ50VlXMe

Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703 #bmtsm BMT CTN Shernan Holtan MD Mehdi Hamadani, MD ascopubs.org/doi/10.1200/JC…

New The EBMT president Dr Ibrahin Yakub-Agha 👏👏 Mohamad Mohty please try and convince him to be on X !

Still surreal ❤️

Managing frail patients with blood diseases is a challenging task, balancing complex treatments with heightened risks and vulnerability. Don’t miss this webinar by ⁦IACH⁩ Free registration: us06web.zoom.us/webinar/regist… ⁦EBMT Nurses⁩ ⁦EBMT_Cellular_Therapy⁩

There is no better way to overcome the trials of cancer then by preventing it. American Cancer Society and Cancer Research UK are working together to bring scientists from around the world, focusing purely on prevention please join us this June in London cancerresearchuk.org/funding-for-re…

Have you seen the new look and features of our practice guidelines app? Search "ASTCT Practice Guidelines" in your devices app store to download now.

Congratulations Pashna N. Munshi MD and team Reena Jayani-Kosarzycki Vanderbilt University Medical Center Vanderbilt Health Dr. jordan berlin

Honoring two giants in #MDSsm at the #MDSF25 MDS Foundation biennial meeting in Rotterdam with life achievement awards to Dr John Bennett (who just turned 91) & Dr Peter Greenberg for their life long immense contributions to the field. We truly stand on the shoulders of giants!

Kudos Dr Irena Hrstic, MD, PhD, for a stimulating and interactive discussion at the European School of Oncology Leadership Development Course, May 9, 2025. A great impetus for the next generation of leaders.

I’ve been in the exercise oncology field for 20 years and for all of that time, the main criticism has been “show me a well controlled RCT.” Well, here it is. Exercise following adjuvant chemotherapy for colon cancer reduced recurrence and improves OVERALL SURVIVAL! #ASCO25

Please check out our paper published today in Nature that identifies CREM as a key checkpoint limiting CAR NK cell function.CRISPR knockout of CREM significantly enhanced anti-tumor activity, implicating a broader role in NK cell regulation. Huge congrats to @hindrafei and our